Ibrutinib | High-Quality Pharmaceutical Reference Standard
Ibrutinib is a Bruton's tyrosine kinase (BTK) inhibitor used in the treatment of B-cell malignancies, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. It works by blocking B-cell receptor signaling, thereby inhibiting malignant cell proliferation. Ibrutinib API is manufactured under GMP standards and is suitable for oral solid dosage formulations, including tablets.
Ibrutinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.
Total Products : 14
